Phospho-GSK-3α/β (Ser21/9) Antibody [N3H2]

Catalogusnr. F0496

Afdrukken

Biologische Beschrijving

Specificiteit Phospho-GSK-3α/β (Ser21/9) Antibody [N3H2] detecteert endogene niveaus van totaal GSK-3α-eiwit alleen wanneer het gefosforyleerd is op Ser21, en ook endogene niveaus van totaal GSK-3β-eiwit alleen wanneer het gefosforyleerd is op Ser9.
Achtergrond Phospho-GSK-3α/β (Ser21/9) vertegenwoordigt de geïnactiveerde vorm van glycogeensynthasekinase-3 (GSK-3), een serine/threonine-proteïnekinasefamilie met twee isovormen, GSK-3α en GSK-3β, die ubiquitair tot expressie komen en oorspronkelijk geïdentificeerd zijn vanwege hun rol in de regulatie van het glycogeenmetabolisme. GSK-3 bezit een N-terminaal gebied dat de belangrijke regulerende serineresiduen Ser21 (in GSK-3α) en Ser9 (in GSK-3β) bevat, die, wanneer gefosforyleerd, fungeren als een pseudo-substraat om competitief de toegang tot de geprimede substraatbindende pocket in het katalytische domein te remmen; activering is verder afhankelijk van Tyr279 (GSK-3α) of Tyr216 (GSK-3β) fosforylering in de activeringsloop. GSK-3 behoudt constitutieve activiteit in ongestimuleerde cellen, maar wordt voornamelijk geïnactiveerd door Ser21/9-fosforylering door kinasen zoals Akt (geactiveerd via de PI3K-route als reactie op groeifactoren, insuline of stressoren), wat substraatdocking blokkeert en de fosforylering van meer dan 100 doelen stopt die een primair fosforesidu vier residuen C-terminaal van de site vereisen. Deze inactivatie bevordert glycogeensynthese, celoverleving, proliferatie en processen zoals Wnt-signalering door GSK-3-gemedieerde afbraak van β-catenine te voorkomen, terwijl het apoptose, tau-hyperfosforylering (relevant voor de ziekte van Alzheimer) en cyclin D1-turnover tegengaat. Defosforylering op Ser21/9 door fosfatasen zoals PP1, PP2A of PP2B reactiveert GSK-3, wat bij ontregeling leidt tot neurodegeneratie, kanker en metabole stoornissen.

Gebruiksinformatie

Toepassing WB, IP Verdunning
WB IP
1:1000 1:50
Reactiviteit Human, Mouse, Rat, Monkey
Bron Rabbit Monoclonal Antibody MW 51 kDa, 46 kDa
Opslagbuffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Opslag
(Vanaf de datum van ontvangst)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referenties

  • https://pubmed.ncbi.nlm.nih.gov/11035810/
  • https://pubmed.ncbi.nlm.nih.gov/25435019/

Toepassingsgegevens

WB

Gevalideerd door Selleck

  • F0496-wb
    Lane 1: COS-7 (λ phosphatase treated), Lane 2: COS-7 (PDGF, 100ng/mL, 5 min)